1. World Health Organization. The importance of pharmacovigilance: safety monitoring of medical products. 2002. http://apps.who.int/medicinedocs/collect/medicinedocs/pdf/s4893e/s4893e.pdf. Accessed 18 Nov 2017.
2. Handbook of resolutions and decisions of the World Health Assembly and Executive Board, Vol 11948-1972. Geneva: World Health Organization, 1973. WHA16.36 Clinical and pharmacological Evaluation of Drugs.
3. Uppsala Monitoring Centre (UMC). WHO Programme members. https://www.who-umc.org/. Accessed 22 Jun 2017.
4. Aagaard L, Soendergaard B, Andersen E, Kampmann JP, Hansen EH. Creating knowledge about adverse drug reactions: a critical analysis of the Danish reporting system from 1968 to 2005. Soc Sci Med. 2007;65(6):1296–309.
5. The International Trade Administration. Top Markets Report Pharmaceuticals Country Case Study. 2016. https://www.trade.gov/topmarkets/pdf/Pharmaceuticals_China.pdf. Accessed 28 Dec 2017.